Archrock, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Archrock, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	807	795	904	965	875	781	846	990	1,158	1,490
Cost of revenue		419	464	456	377	359	419	449	459	509
Gross profit		376	440	509	498	423	262	375	506	724
Selling, general and administrative	114	111	102	118	105	107	117	117	139	148
Interest expense	83.9	88.8	93.3	105	106	108	101	111	124	165
Other non-operating income	8.59	0.24	0.16	0.66	1.36	4.71	-1.85	-1.09	-1.56	-0.44
Pre-tax income	-89.4	-42.6	35.3	58.5	-86	39	60.6	142	232	424
Income tax	-24.6	-61.1	6.15	-39.1	-17.5	10.7	16.3	37.2	60.1	101
Income from continuing operations	-54.1	19	21.1	97.6	-68.4	28.2
Net income to minority interests	-10.7	-0.54	8.1	0
Net income	-54.6	19	21.1	97.3	-68.4	28.2	44.3	105	172	322
EPS, basic	-0.80	0.26	0.19	0.70	-0.46	0.18	0.28	0.67	1.05	1.83
EPS, diluted	-0.80	0.26	0.19	0.70	-0.46	0.18	0.28	0.67	1.05	1.83
Shares, basic (weighted)	69	69.6	109	137	151	152	153	154	162	174
Shares, diluted (weighted)	69	69.7	109	138	151	152	153	154	162	175
Dividend per share	0.50	0.48	0.50	0.55	0.58	0.58	0.58	0.61	0.67	0.80

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	3.13	10.5	5.61	3.69	1.1	1.57	1.57	1.34	4.42	1.55
Receivables	112	113	148	145	104	105	112	120	132	142
Inventory	93.8	90.7	76.3	74.5	63.7	72.9	84.6	81.8	89.7	110
Other current assets	6.08	6.22	10.7	9.19	12.8	7.2	8.23	5.99	6.54	9.06
Total current assets	216	221	256	232	182	187	232	213	233	304
Property, plant and equipment	2,079	2,077	2,171	2,559	2,390	2,227	2,199	2,302	3,324	3,658
Lease right-of-use assets				17.9	19.2	17.5	16.7	14.1	15.4	13.6
Goodwill			0	101				0	52.2	125
Intangible assets	86.7	68.9	52.4	77.5	61.5	47.9	37.1	30.2	98.3	144
Other non-current assets	13.2	27.8	22.6	29.9	30.1	28.4	37.1	47.7	52.9	55.4
Total assets	2,415	2,408	2,553	3,110	2,780	2,590	2,599	2,656	3,824	4,349
Accounts payable	32.5	54.6	54.9	60.2	30.8	38.9	64.3	61	57.6	43.7
Accrued liabilities	69.6	71.1	79	67.8	77	82.5	76.9	85.4	124	145
Deferred revenue	3.45	4.86	16.5	10.7	3.88	3.82	7.33	5.74	6.93	8.39
Total current liabilities	107	131	151	139	112	125	149	152	189	197
Long-term debt	1,442	1,417	1,530	1,843	1,689	1,531	1,548	1,585	2,198	2,411
Lease liabilities				16.1	16.9	15.9	14.9	12.3	12.4	10.2
Other non-current liabilities	7.91	20.1	20.8	16.8	18.1	17.5	17.6	22.9	30.9	33.4
Total liabilities	1,730	1,672	1,711	2,024	1,844	1,699	1,738	1,785	2,501	2,858
Total debt	1,442	1,430	1,540	863	393	1,531	1,548	1,585	2,198	2,411
Paid-in capital	3,021	3,093	3,178	3,413	3,425	3,440	3,457	3,471	3,881	3,877
Retained earnings	-2,227	-2,241	-2,264	-2,245	-2,402	-2,463	-2,509	-2,500	-2,438	-2,257
Treasury stock	-73.9	-76.7	-79.9	-81.9	-83.7	-86.1	-88.6	-101	-121	-130
Other comprehensive income	-1.68	1.2	5.77	-1.39	-5.01	-0.98
Shareholders' equity	719	777	842	1,086	936	891	861	871	1,324	1,491
Minority interests	-34	-41.4	0
Total equity	685	736	842	1,086	936	891	861	871	1,324	1,491
Total liabilities and equity	2,415	2,408	2,553	3,110	2,780	2,590	2,599	2,656	3,824	4,349

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	-65.2	18.4	29.2	97.3	-68.4	28.2	44.3	105	172	322
Depreciation and amortization	209	189	175	188	193	179	164	166	193	257
Stock-based compensation	8.97	8.46	7.39	8.11	10.6	11.3	11.9	13	14.6	19
Deferred income tax	-25	-59.8	5.24	-39.6	-17.8	10.4	15.2	35.7	58.1	97.8
Change in inventory	29.3	-0.24	4.21	6.04	3.97	-13	-10.5	4.19	-1.92	-10.5
Change in payables	-21.9	9.62	15	-12.7	-15.1	5.27	13.5	-12.2	-15.9	3.5
Cash from operations	274	202	226	290	335	237	203	310	430	622
Capital expenditures	-118	-222	-319	-385	-140	-97.9	-240	-299	-359	-502
Acquisitions	-13.8	0	0	-214					-866
Purchases of investments							-14.7	-7.29	-2.5	-5.47
Cash from investing	-89.5	-174	-285	-515	-85	16.1	-131	-232	-1,160	-607
Debt issued	537	1,242	715	2,395	1,049	705	827	803	1,430	2,143
Debt repaid	-675	-1,270	-606	-2,072	-1,204	-863	-810	-767	-1,308	-1,633
Stock issued	0	0.99	0.26	0		3.4	4.18		256
Share buybacks	-1.52	-2.79	-1.76	-2.01	-1.8	-2.47	-2.45	-8.86	-13.3	-70.2
Dividends paid	-34.9	-34.1	-58.3	-78.5	-88.8	-89.3	-90.3	-95.8	-110	-142
Cash from financing	-183	-19.8	54.1	222	-253	-253	-72.5	-77.9	734	-18.1
Exchange rate effect	0
Net change in cash	1.57	7.4	-4.93	-1.93	-2.59	0.47	-0	-0.23	3.08	-2.87
Free cash flow	157	-20	-93.2	-95.1	195	140	-36.4	11.6	70.6	120
Interest paid	78	78.9	86.8	97.5	99.8	100	98.4	108	121	161
Income taxes paid	-3.99	-0.7	-2.13	-1.97	0.09	0.25	0.41	1.31	2.21	3.29

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $30.43 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	48.9%	Gross profit / revenue.
Pre-tax margin	29.0%	Pre-tax income / revenue.
Net margin	21.8%	Net income / revenue.
FCF margin	19.4%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	48.2%	Cash from operations / revenue.
Effective tax rate	24.4%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	21.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	7.4%	Net income / average total assets.
SG&A / revenue	10.6%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	1.6%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	28.9%	Capital expenditures / revenue.
D&A / revenue	18.4%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	28.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	20.8%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	11.2%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	43.0%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	40.3%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	7.8%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	87.1%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	93.8%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS growth, 1y	74.3%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	87.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow growth, 1y	44.8%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	45.1%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	13.2%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	69.6%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 5y	-9.3%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	19.4%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	11.3%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	6.6%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	12.7%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	20.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	9.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	13.7%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	18.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	9.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	7.6%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	4.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	3.0%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.39x	Current assets / current liabilities.
Quick ratio	0.88x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.01x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.51x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	52.8%	Total debt / total assets.
Liabilities / assets	65.1%	Total liabilities / total assets.
Net debt	$2.35B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$96.8M	Current assets - current liabilities.
Goodwill and intangibles / assets	5.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	$1.29B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.34x	Revenue / average total assets.
Fixed asset turnover	0.40x	Revenue / average property, plant and equipment.
Inventory turnover	4.39x	Cost of revenue / average inventory.
Days inventory	83 days	365 x average inventory / cost of revenue.
Receivables turnover	6.98x	Revenue / average receivables.
Days sales outstanding	52 days	365 x average receivables / revenue.
Days payables	49 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	87 days	Days inventory + days sales outstanding - days payables.
FCF conversion	88.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	59.9%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$1.88	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$8.61	Revenue / diluted weighted shares.
FCF per share	$1.67	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4.15	Cash from operations / diluted weighted shares.
Book value per share	$8.88	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$7.39	Tangible book value / shares outstanding.
Cash per share	$0.01	(Cash + short-term investments) / shares outstanding.
Payout ratio	46.4%	Dividends paid / net income, when net income is positive.
Dividends / FCF	52.3%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	15.7%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$5.34B	Share price x shares outstanding.
Enterprise value	$7.68B	Market cap + total debt - cash - short-term investments.
P/E	16.2x	Market cap / net income. Only when net income is positive.
P/S	3.55x	Market cap / revenue.
P/B	3.44x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	4.13x	Market cap / tangible book value, when positive.
P/FCF	18.3x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	7.35x	Market cap / cash from operations, when positive.
EV/Sales	5.11x	Enterprise value / revenue.
EV/FCF	26.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	5.5%	Free cash flow / market cap.
Earnings yield	6.2%	Net income / market cap (the inverse of P/E).
Dividend yield	2.9%	Dividends paid over the period / market cap.
Shareholder yield	3.7%	(Dividends paid + share buybacks) / market cap.
PEG	0.19x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was Archrock, Inc.'s revenue in fiscal 2025?

Archrock, Inc. reported revenue of $1.49B for fiscal 2025, 28.7% higher than the year before.

Was Archrock, Inc. profitable in fiscal 2025?

Yes. Net income was $322.3M, a net margin of 21.6%.

How much free cash flow did Archrock, Inc. generate in fiscal 2025?

Cash from operations of $622.1M minus capital expenditures of $502.5M left free cash flow of $119.6M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Archrock, Inc.